Haemonetics HAE Payments for purchase of capped call related to convertible notes
Payments for purchase of capped call related to convertible notes at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept hae:PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes.
The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's payments for purchase of capped call related to convertible notes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's payments for purchase of capped call related to convertible notes?
- Haemonetics (HAE) reported payments for purchase of capped call related to convertible notes of $0 in Q1 2026.
- How has Haemonetics's payments for purchase of capped call related to convertible notes changed year-over-year?
- Haemonetics's payments for purchase of capped call related to convertible notes decreased by 100.0% year-over-year, from $22.05M to $0.
- What does payments for purchase of capped call related to convertible notes mean?
- This represents the cash outflow for purchasing derivative instruments designed to mitigate the potential dilution from convertible debt securities. These instruments effectively raise the conversion price of the debt, protecting existing shareholders from excessive equity dilution. It reflects the company's strategy for managing capital structure and equity-linked financing costs.